Latest New Zealand News

Myer Holdings reported a 13.8% revenue increase in FY25, boosted by its acquisition of Apparel Brands, yet faced a statutory net loss of $211.2 million due to goodwill impairment. The integration of Apparel Brands is underway, with strategic growth initiatives in motion.

Alcidion Group has expanded its contract with North Cumbria Integrated Care NHS Foundation Trust to integrate MediViewer into its Miya Precision electronic patient record system, enhancing access to scanned and historical documents.

Clover Corp has reported a standout FY25 with robust revenue and profit growth, driven by new product launches and strategic investments that strengthen its global supply chain and market reach.

Clover Corporation posted a robust 38% revenue increase to $86 million in FY25, driven by product innovation and operational gains, while declaring a final dividend. The company’s cautious outlook for FY26 reflects ongoing regulatory and production challenges.

Shriro Holdings has reversed its plan to delist from the ASX and scrap a $5 million share buy-back, now considering a special dividend to reward shareholders.

Domino’s Pizza Enterprises has updated its dividend announcement to include a DRP price of AUD 14.26 with a 1% discount, alongside an unfranked dividend of AUD 0.215 per share for the half-year ending June 2025.

Iluka Resources has updated its dividend details for the first half of 2025, confirming a fully franked dividend of 2 cents per share and announcing a Dividend Reinvestment Plan price of AUD 6.0274.

Wellnex Life has secured a significant opening order from global partner Haleon for its Liquid Paracetamol and Ibuprofen softgel products in the UAE, marking the fourth national market in Haleon's distribution network. This milestone supports Wellnex's revenue forecasts for 2025 and underscores its strategic focus on innovative healthcare products.

Thrive Tribe Technologies is raising up to A$618,736 through a discounted entitlement offer to existing shareholders in Australia, New Zealand, and Malaysia. The capital raise aims to bolster working capital and cover offer expenses.

Memphasys Limited has secured $0.84 million through a placement and announced a rights issue to raise up to $1.12 million, sharply cutting operating costs to accelerate commercialisation and manufacturing scale-up of its Felix™ bioseparation system.

Reece Limited has announced an off-market share buy-back targeting $250 million, with flexibility up to $400 million, offering shareholders a premium price range between $11.00 and $13.00 per share. This move aims to return excess capital while preserving financial flexibility for future growth.

Nimy Resources has launched a $2.5 million Share Purchase Plan offering shares at a 15.28% discount to eligible shareholders, aiming to accelerate copper exploration and finalize a gallium resource.